Male CP/CPPS: where do we stand?

Introduction Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), commonly encountered in urologic practice, carries with it a stigma of poor understanding, ineffective treatment, and significant financial and quality of life burden. Materials and methods This clinically practical review is b...

Full description

Saved in:
Bibliographic Details
Published in:World journal of urology 2019-06, Vol.37 (6), p.1015-1022
Main Authors: Doiron, R. Christopher, Shoskes, Daniel A., Nickel, J. Curtis
Format: Article
Language:English
Subjects:
Chronic pain
Humans
Male
Medical innovations
Medicine
Medicine & Public Health
Microbiomes
Nephrology
Oncology
Patients
Prostatitis
Prostatitis - diagnosis
Prostatitis - therapy
Quality of life
Topic Paper
Urology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), commonly encountered in urologic practice, carries with it a stigma of poor understanding, ineffective treatment, and significant financial and quality of life burden. Materials and methods This clinically practical review is based on the authors’ personal clinical experience in interpretation and application of currently available evidence. Results Significant progress has been made in terms of classification and evaluation of the disease, leading to encouraging improvements in treatment outcomes. The Chronic Prostatitis Symptom Index (CPSI) is a helpful tool in clinical evaluation and has proven invaluable for research purposes, while UPOINT has demonstrated the heterogeneity of the disease and provides physicians with a uniquely patient-centered approach to treatment. The importance of the microbiome in the evaluation of CP/CPPS patients has yet to be fully appreciated. While personalized, multi-modal therapy appears to be the key to treatment, the addition of pelvic floor physiotherapy (PFPT) with injection of trigger points, and psychosocial therapies to the multi-modal approach armamentarium are promising advances. Innovative interventional approaches are encouraging but require study. Conclusions While encouraging therapies have been added to personalized, multi-modal treatment strategies, newer innovative therapies appear promising for improved treatment of CP/CPPS patients.
ISSN:0724-4983
1433-8726
DOI:10.1007/s00345-019-02718-6